Conclusions-Repeated attacks of acute chest syndrome by the mean age of 12 (range eight to 16) years have not had a discernible effect upon pulmonary artery pressure. (Br Heart3J 1993;69:536-538) 
Pulmonary fibrosis, and consequently pulmonary hypertension, are believed to compromise right ventricular function resulting in cor pulmonale in some patients with homozygous sickle cell disease. The acute chest syndrome representing a complex pathology of infection, infarction, and pulmonary sequestration is a common cause of morbidity and mortality in homozygous sickle cell disease. The Jamaican cohort study in which children with this disease have been followed up prospectively from birth provides an opportunity to assess the effect of repeated episodes of the acute chest syndrome on pulmonary artery pressure. We report pulmonary haemodynamic findings in 20 age and sex matched pairs with homozygous sickle cell disease with and without a history of multiple episodes of the acute chest syndrome.
Patients and methods
The patients attended the sickle cell clinic of the University Hospital of the West Indies, Kingston, Jamaica, and participated in a cohort study of sickle cell disease. Left ventricular ejection fraction was estimated from the formula: LVEF = 1-(As/Ad) x (Ds/Dd2)
where As/Ad was the ratio of left ventricular end systolic and end diastolic major axis dimensions and was assumed to be 0-9, corresponding to a 10% shortening of this axis. The stroke volume was derived from the product of left ventricular end diastolic volume and ejection fraction. Cardiac output was calculated from the stroke volume and heart rate.
PULSED DOPPLER TECHNIQUE
Pulmonary artery velocities were recorded with the sample volume just beyond the pulmonary valve in the parasternal short axis view according to the method of Kitabatake et al. 5 The acceleration time (ACT) was measured as the time to peak velocity. Mean pulmonary artery pressure (mean PAP) was estimated by the formula:
mean PAP = 79 -045 ACT corr where ACT corr = ACT (ms) + R R interval.
Tricuspid regurgitation velocity, where recordable, was measured in the parasternal short axis or four chamber view. Pulmonary artery systolic pressure (PAs) was assumed to be equal to right ventricular systolic pressure in the absence of pulmonary stenosis. Right ventricular systolic pressure was calculated by adding 14 mm to the right ventricular to right atrial pressure gradient deduced from the modified Bernoulli equation, pressure gradient (mm Hg) = 4 velocity2.
Pulmonary regurgitant velocity when present was recorded in the parasternal short axis view. The pulmonary artery to right ventricular pressure gradient was calculated from the modified Bernoulli equation and the pulmonary artery diastolic pressure (PAd) calculated by adding 8 mm to this gradient.
Pulmonary vascular resistance was calculated by dividing the pulmonary artery pressure by the cardiac index.
Results
The drome. No significant differences between the groups were found. Tricuspid regurgitation allowed the calculation of pulmonary artery systolic pressure in 6/20 with a history of the acute chest syndrome and in 8/20 controls. Pulmonary regurgitation allowed the calculation of pulmonary artery diastolic pressure in 7/20 with a history of the acute chest syndrome and in 11/20 controls.
Discussion
Patients with sickle cell disease are more prone to attacks of acute pulmonary pathology that in the absence of a clear pathological mechanism is usually referred to as the acute chest syndrome. In the Jamaican cohort study of sickle cell disease, the incidence of the acute chest syndrome was four times greater than in normal controls by the age of four years.6 Although the acute chest syndrome is an important cause of morbidity and mortality at all ages,7 it is unclear whethei patients recovering from attacks sustain permanent damage to the alveolar or pulmonary capillary system. A recent review of experience with acute chest syndrome in the cohort study noted that 31 patients had had six episodes or more by a mean age of 12 years and controlled observations in 20 of these patients noted a significant reduction in peak expiratory flow (PEF) compared with 20 controls with homozygous sickle cell disease matched for age, sex, and height who had never had the acute chest syndrome.8 The mechanism of reduction in PEF was not clearly understood and could not be investigated further in the absence of other pulmonary function tests, but one possibility was an increased pulmonary fibrosis.
Such a diffuse pulmonary fibrosis might also be expected to reduce the distensibility of pulmonary arterioles and capillaries contributing to an increase in pulmonary artery pressure. It was therefore of interest to study pulmonary artery pressure in the same 20 matched pairs previously studied by PEF to find whether repeated attacks of acute chest syndrome had resulted in an increase in pulmonary artery pressure. We have not detected any significant differences in echocardiographic or Doppler values between the two groups.
This finding is open to several interpretations. The acute chest syndrome may resolve completely without permanent fibrotic changes. The reduction in PEF noted in these children, however, indicates some residual change and Powars et al found a strong co-relation between number of acute chest syndrome events and chronic pulmonary fibrosis (sickle cell chronic lung disease).9 It is possible that the number of clinical events in these children is still too few to permanently compromise pulmonary vascular flow and that more years of pulmonary events are necessary to exceed the adaptive capacity of the pulmonary vascular bed. This is plausible although Powars et Although the present study has not used cardiac catheterisation, the validity of the non-invasive method of deriving pulmonary artery systolic pressure from the tricuspid regurgitant velocity has been well documented by simultaneous Doppler and catheterisation studies.'2 Also, the mean pulmonary artery pressure calculated for heart rate correlates well with invasively determined systolic and mean pulmonary artery pressure. 13 There is no reason to believe that this method is invalidated by the cardiovascular changes of sickle cell disease and prospective studies will be continued to clarify the relation between acute chest syndrome events and pulmonary artery pressure in these patients.
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